hubtechinsider.wordpress.com
Epizyme, based in Cambridge and working on cancer-fighting genetic drugs, has raised $32 Million from a diverse group of investors including Kleiner Perkins, Amgen and Astrellas Pharma
Epizyme, based in Cambridge and working on cancer-fighting genetic drugs, has raised $32 Million from a diverse group of investors including Kleiner Perkins, Amgen and Astrellas Pharma